Evaluating HER2 in Gastroesophageal Cancer.

@article{2017EvaluatingHI,
  title={Evaluating HER2 in Gastroesophageal Cancer.},
  author={},
  journal={Cancer discovery},
  year={2017},
  volume={7 1},
  pages={OF1}
}
New evidence-based guidelines for HER2 testing in patients with gastroesophageal adenocarcinoma aim to improve treatment by determining who might benefit from targeted therapies.